INmune Bio, Inc.
INMB
$1.98
-$0.03-1.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.46M | -9.74M | -9.22M | -12.09M | -9.75M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | 6.00K | 15.00K | 24.00K |
| Total Other Non-Cash Items | 18.05M | 2.08M | 1.76M | 1.72M | 2.35M |
| Change in Net Operating Assets | -965.00K | 839.00K | -3.56M | 3.37M | -514.00K |
| Cash from Operations | -7.38M | -6.82M | -11.01M | -6.99M | -7.89M |
| Capital Expenditure | -706.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -706.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -2.50M | -2.50M | -2.50M |
| Issuance of Common Stock | 22.27M | 5.27M | 422.00K | 12.29M | 15.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 22.27M | 5.27M | -2.08M | 9.79M | 13.00M |
| Foreign Exchange rate Adjustments | -153.00K | -35.00K | 461.00K | -323.00K | -44.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.04M | -1.59M | -12.63M | 2.48M | 5.07M |